June 2026. Volume 22. Number 2

Ivermectin as a complementary tool for malaria vector control

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Chaccour C, Maia M, Kariuki M, Ruiz-Castillo P, Wanjiku C, Kasiwa l, et al. Ivermectin to control malaria - A cluster-randomized trial. N Engl J Med. 2025;393:362-75.

Reviewers: Fraile Astorga G1, Cuestas Montañés EJ2.
1Pediatra. CS Cuellar. Segovia. España.
2Servicio de Pediatría y Neonatología. Hospital Privado Universitario de Córdoba. Córdoba. Argentina.
Correspondence: Garazi Fraile Astorga. Email: gfrailea@saludcastillayleon.es
Reception date: 30/03/2026
Acceptance date: 06/04/2026
Publication date: 15/04/2026

Abstract

Authors´ conclusions: among children 5 to 15 years of age who were living in an area with high coverage and use of bed nets, ivermectin, administered once a month for 3 consecutive months, resulted in a 26% lower incidence of malaria infection than albendazole. No safety concerns were identified.

Reviewers´ commentary: the BOHEMIA trial shows that mass administration of ivermectin reduces malaria incidence by 26% (NNT = 4.3 over 6 months), with an acceptable safety profile and programmatic potential as a complementary tool against insecticide resistance. Although methodological limitations warrant caution, the evidence supports its consideration within integrated strategies, with further research needed on effectiveness under real-world conditions and in vulnerable populations.

How to cite this article

Fraile Astorga G, Cuestas Montañés E. Ivermectina como herramienta complementaria para el control vectorial de la malaria. Evid Pediatr. 2026;22:11.

AVC | Critically appraised articles

Chaccour C, Maia M, Kariuki M, Ruiz-Castillo P, Wanjiku C, Kasiwa l, et al. Ivermectin to control malaria - A cluster-randomized trial. N Engl J Med. 2025;393:362-75.

Reviewers: Fraile Astorga G1, Cuestas Montañés EJ2.
1Pediatra. CS Cuellar. Segovia. España.
2Servicio de Pediatría y Neonatología. Hospital Privado Universitario de Córdoba. Córdoba. Argentina.
Correspondence: Garazi Fraile Astorga. Email: gfrailea@saludcastillayleon.es
Reception date: 30/03/2026
Acceptance date: 06/04/2026
Publication date: 15/04/2026

How to cite this article

Fraile Astorga G, Cuestas Montañés E. Ivermectina como herramienta complementaria para el control vectorial de la malaria. Evid Pediatr. 2026;22:11.

15/04/2026

Linked Comment

Methodological note